(-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of NRP1 mRNA CTD PMID:23649840 1,1-dichloroethene decreases expression ISO RGD:1552955 6480464 vinylidene chloride results in decreased expression of NRP1 mRNA CTD PMID:26682919 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of NRP1 mRNA CTD PMID:18936297 17beta-estradiol increases expression ISO RGD:1552955 6480464 Estradiol results in increased expression of NRP1 mRNA CTD PMID:14664709 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of NRP1 mRNA CTD PMID:20660070 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NRP1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1552955 6480464 Tetrachlorodibenzodioxin results in decreased expression of NRP1 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NRP1 mRNA CTD PMID:20106945 , PMID:21632981 3,3',5-triiodo-L-thyronine increases expression ISO RGD:621588 6480464 Triiodothyronine results in increased expression of NRP1 mRNA CTD PMID:15953391 3-chloropropane-1,2-diol increases expression ISO RGD:621588 6480464 alpha-Chlorohydrin results in increased expression of NRP1 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP1 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression ISO RGD:621588 6480464 1, 2-dithiol-3-thione results in decreased expression of NRP1 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of NRP1 mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol increases expression ISO RGD:1552955 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NRP1 mRNA CTD PMID:30951980 4-hydroxynon-2-enal increases expression ISO RGD:1552955 6480464 4-hydroxy-2-nonenal results in increased expression of NRP1 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1552955 6480464 Fenretinide results in increased expression of NRP1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 [Decitabine co-treated with Depsipeptides] results in decreased expression of NRP1 mRNA, Decitabine inhibits the reaction [Smoke results in decreased expression of NRP1 mRNA] CTD PMID:17064661 , PMID:21095227 5-fluorouracil decreases response to substance EXP 6480464 NRP1 protein results in decreased susceptibility to Fluorouracil CTD PMID:15956974 8-bromo-3',5'-cyclic AMP increases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NRP1 mRNA CTD PMID:22079614 acetaldehyde affects expression ISO RGD:1552955 6480464 Acetaldehyde affects the expression of NRP1 mRNA CTD PMID:22634333 acrylamide decreases expression ISO RGD:621588 6480464 Acrylamide results in decreased expression of NRP1 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1552955 6480464 Aflatoxin B1 results in increased expression of NRP1 mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of NRP1 mRNA CTD PMID:27153756 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of NRP1 protein CTD PMID:20106945 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of NRP1 mRNA CTD PMID:21934132 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of NRP1 mRNA CTD PMID:23724009 ammonium chloride affects expression ISO RGD:621588 6480464 Ammonium Chloride affects the expression of NRP1 mRNA CTD PMID:16483693 amphetamine decreases expression ISO RGD:621588 6480464 Amphetamine results in decreased expression of NRP1 mRNA CTD PMID:30779732 antimycin A decreases expression ISO RGD:1552955 6480464 Antimycin A results in decreased expression of NRP1 mRNA CTD PMID:19304788 arsenite(3-) increases methylation EXP 6480464 arsenite results in increased methylation of NRP1 promoter CTD PMID:23974009 belinostat increases expression EXP 6480464 belinostat results in increased expression of NRP1 mRNA CTD PMID:26272509 belinostat multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of NRP1 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of NRP1 mRNA CTD PMID:20106945 more ... benzo[a]pyrene decreases expression ISO RGD:1552955 6480464 Benzo(a)pyrene results in decreased expression of NRP1 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bicalutamide decreases expression EXP 6480464 bicalutamide results in decreased expression of NRP1 mRNA CTD PMID:15638997 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NRP1 mRNA CTD PMID:20170705 bisphenol A increases expression ISO RGD:1552955 6480464 bisphenol A results in increased expression of NRP1 mRNA CTD PMID:30951980 bisphenol A multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP1 mRNA CTD PMID:28628672 bisphenol A increases methylation ISO RGD:1552955 6480464 bisphenol A results in increased methylation of NRP1 promoter CTD PMID:27312807 bisphenol A affects expression ISO RGD:621588 6480464 bisphenol A affects the expression of NRP1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1552955 6480464 bisphenol A results in decreased expression of NRP1 mRNA CTD PMID:26063408 Bisphenol A diglycidyl ether multiple interactions ISO RGD:1552955 6480464 [2, 2-bis(4-glycidyloxyphenyl)propane co-treated with Cytarabine] results in decreased expression of NRP1 mRNA CTD PMID:23264188 bisphenol F increases expression ISO RGD:1552955 6480464 bisphenol F results in increased expression of NRP1 mRNA CTD PMID:30951980 butanal decreases expression EXP 6480464 butyraldehyde results in decreased expression of NRP1 mRNA CTD PMID:26079696 calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of NRP1 mRNA CTD PMID:16002434 capsaicin increases expression ISO RGD:621588 6480464 Capsaicin results in increased expression of NRP1 protein CTD PMID:22150557 capsaicin multiple interactions ISO RGD:621588 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NRP1 protein] more ... CTD PMID:22150557 carbamazepine affects expression ISO RGD:1552955 6480464 Carbamazepine affects the expression of NRP1 mRNA CTD PMID:22634333 carbon nanotube increases expression ISO RGD:1552955 6480464 Nanotubes, Carbon analog results in increased expression of NRP1 mRNA, Nanotubes, Carbon results in increased expression of NRP1 mRNA CTD PMID:25620056 choline multiple interactions ISO RGD:1552955 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NRP1 mRNA CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO RGD:1552955 6480464 Ciguatoxins affects the expression of NRP1 mRNA CTD PMID:18353800 cisplatin multiple interactions EXP 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of NRP1 mRNA CTD PMID:21858171 clofibrate increases expression ISO RGD:1552955 6480464 Clofibrate results in increased expression of NRP1 mRNA CTD PMID:17585979 clofibrate multiple interactions ISO RGD:1552955 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NRP1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NRP1 mRNA] CTD PMID:17585979 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of NRP1 mRNA CTD PMID:19320972 , PMID:19376846 cobalt dichloride decreases expression ISO RGD:621588 6480464 cobaltous chloride results in decreased expression of NRP1 mRNA CTD PMID:24386269 cocaine increases expression ISO RGD:621588 6480464 Cocaine results in increased expression of NRP1 mRNA CTD PMID:15691709 copper atom multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of NRP1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of NRP1 mRNA CTD PMID:20971185 , PMID:24690739 copper atom multiple interactions ISO RGD:1552955 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NRP1 mRNA CTD PMID:15467011 copper(0) multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of NRP1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of NRP1 mRNA CTD PMID:20971185 , PMID:24690739 copper(0) multiple interactions ISO RGD:1552955 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NRP1 mRNA CTD PMID:15467011 cyclophosphamide decreases expression ISO RGD:1552955 6480464 Cyclophosphamide results in decreased expression of NRP1 mRNA CTD PMID:15331540 cyclophosphamide increases expression ISO RGD:621588 6480464 Cyclophosphamide results in increased expression of NRP1 mRNA CTD PMID:18632792 cyclosporin A affects expression EXP 6480464 Cyclosporine affects the expression of NRP1 mRNA CTD PMID:20106945 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of NRP1 mRNA CTD PMID:27989131 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of NRP1 mRNA CTD PMID:21632981 cytarabine multiple interactions ISO RGD:1552955 6480464 [2, 2-bis(4-glycidyloxyphenyl)propane co-treated with Cytarabine] results in decreased expression of NRP1 mRNA CTD PMID:23264188 depsipeptide multiple interactions EXP 6480464 [decitabine co-treated with Depsipeptides] results in decreased expression of NRP1 mRNA CTD PMID:17064661 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP1 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:1552955 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NRP1 mRNA CTD PMID:29950665 dibutyl phthalate increases expression ISO RGD:1552955 6480464 Dibutyl Phthalate results in increased expression of NRP1 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:621588 6480464 Dibutyl Phthalate results in decreased expression of NRP1 mRNA CTD PMID:21266533 diclofenac increases expression ISO RGD:1552955 6480464 Diclofenac results in increased expression of NRP1 mRNA CTD PMID:26934552 dicrotophos decreases expression EXP 6480464 dicrotophos results in decreased expression of NRP1 mRNA CTD PMID:28302478 diethylstilbestrol increases expression ISO RGD:1552955 6480464 Diethylstilbestrol results in increased expression of NRP1 mRNA CTD PMID:14664709 dioxygen multiple interactions ISO RGD:1552955 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRP1 mRNA CTD PMID:30529165 disodium selenite multiple interactions ISO RGD:1552955 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NRP1 mRNA CTD PMID:23274088 disulfiram multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of NRP1 mRNA CTD PMID:24690739 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance EXP 6480464 NRP1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of NRP1 mRNA CTD PMID:29803840 entinostat increases expression EXP 6480464 entinostat results in increased expression of NRP1 mRNA CTD PMID:26272509 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 enzacamene increases expression EXP 6480464 enzacamene results in increased expression of NRP1 mRNA CTD PMID:30597193 ethanol decreases expression ISO RGD:621588 6480464 Ethanol results in decreased expression of NRP1 mRNA CTD PMID:15353170 ethanol increases expression ISO RGD:1552955 6480464 Ethanol results in increased expression of NRP1 mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:1552955 6480464 Ethanol affects the expression of NRP1 mRNA CTD PMID:22198099 , PMID:30319688 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of NRP1 protein CTD PMID:20621659 ferric oxide decreases expression ISO RGD:1552955 6480464 ferric oxide analog results in decreased expression of NRP1 mRNA CTD PMID:25086211 flavonoids increases expression ISO RGD:621588 6480464 Flavonoids results in increased expression of NRP1 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:1552955 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NRP1 mRNA CTD PMID:20938992 folic acid increases expression ISO RGD:1552955 6480464 Folic Acid results in increased expression of NRP1 mRNA CTD PMID:25006883 furan increases methylation ISO RGD:621588 6480464 furan results in increased methylation of NRP1 gene CTD PMID:22079235 gemcitabine decreases response to substance EXP 6480464 NRP1 protein results in decreased susceptibility to gemcitabine CTD PMID:15956974 genistein affects expression EXP 6480464 Genistein affects the expression of NRP1 mRNA CTD PMID:16399490 gentamycin increases expression ISO RGD:621588 6480464 Gentamicins results in increased expression of NRP1 mRNA CTD PMID:22061828 graphite affects expression ISO RGD:621588 6480464 Graphite affects the expression of NRP1 mRNA CTD PMID:29933104 hypochlorous acid increases expression ISO RGD:1552955 6480464 Hypochlorous Acid results in increased expression of NRP1 mRNA CTD PMID:19376150 indoles increases expression ISO RGD:621588 6480464 Indoles results in increased expression of NRP1 mRNA CTD PMID:20521778 indoles decreases expression ISO RGD:621588 6480464 Indoles results in decreased expression of NRP1 mRNA CTD PMID:20521778 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRP1 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO RGD:1552955 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NRP1 mRNA CTD PMID:20938992 leflunomide increases expression ISO RGD:621588 6480464 leflunomide results in increased expression of NRP1 mRNA CTD PMID:24136188 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of NRP1 mRNA CTD PMID:28988120 manganese atom increases expression EXP 6480464 Manganese results in increased expression of NRP1 mRNA CTD PMID:17175027 manganese(0) increases expression EXP 6480464 Manganese results in increased expression of NRP1 mRNA CTD PMID:17175027 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of NRP1 mRNA CTD PMID:17175027 melphalan decreases expression EXP 6480464 Melphalan results in decreased expression of NRP1 mRNA CTD PMID:22363485 mercury dibromide increases expression EXP 6480464 mercuric bromide results in increased expression of NRP1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of NRP1 mRNA CTD PMID:21678067 N-acetylsphingosine multiple interactions EXP 6480464 sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP1 mRNA] CTD PMID:15741222 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:621588 6480464 Methylnitronitrosoguanidine results in increased expression of NRP1 mRNA CTD PMID:15120970 naproxen multiple interactions ISO RGD:621588 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NRP1 protein], Naproxen inhibits the reaction [Capsaicin results in increased expression of NRP1 protein] CTD PMID:22150557 nickel dichloride decreases expression ISO RGD:1552955 6480464 nickel chloride results in decreased expression of NRP1 mRNA CTD PMID:12839937 nitrobenzenes increases expression ISO RGD:621588 6480464 Nitrobenzenes analog results in increased expression of NRP1 mRNA CTD PMID:19784758 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of NRP1 protein CTD PMID:18790786 oxaliplatin multiple interactions ISO RGD:621588 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NRP1 mRNA CTD PMID:25729387 p-menthan-3-ol increases expression EXP 6480464 Menthol results in increased expression of NRP1 mRNA CTD PMID:26760959 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of NRP1 mRNA CTD PMID:19682730 panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 panobinostat increases expression EXP 6480464 panobinostat results in increased expression of NRP1 mRNA CTD PMID:26272509 paracetamol multiple interactions ISO RGD:1552955 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of NRP1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NRP1 mRNA] CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of NRP1 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol increases expression ISO RGD:621588 6480464 Acetaminophen results in increased expression of NRP1 mRNA CTD PMID:19784758 paracetamol affects expression ISO RGD:621588 6480464 Acetaminophen affects the expression of NRP1 mRNA CTD PMID:19784758 paracetamol decreases expression ISO RGD:621588 6480464 Acetaminophen results in decreased expression of NRP1 mRNA CTD PMID:19784758 PD 0325901 multiple interactions EXP 6480464 [PD 0325901 co-treated with (+)-JQ1 compound] results in decreased expression of NRP1 mRNA CTD PMID:25119042 PD 0325901 decreases expression EXP 6480464 PD 0325901 results in decreased expression of NRP1 mRNA CTD PMID:25119042 perfluorooctane-1-sulfonic acid affects expression ISO RGD:1552955 6480464 perfluorooctane sulfonic acid affects the expression of NRP1 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:621588 6480464 perfluorooctane sulfonic acid results in decreased expression of NRP1 mRNA CTD PMID:19162173 perfluorooctanoic acid affects expression ISO RGD:1552955 6480464 perfluorooctanoic acid affects the expression of NRP1 mRNA CTD PMID:19429403 perfluorooctanoic acid decreases expression ISO RGD:621588 6480464 perfluorooctanoic acid results in decreased expression of NRP1 mRNA CTD PMID:19162173 phenobarbital multiple interactions ISO RGD:1552955 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of NRP1 mRNA] CTD PMID:19482888 phenobarbital decreases expression ISO RGD:1552955 6480464 Phenobarbital results in decreased expression of NRP1 mRNA CTD PMID:19482888 , PMID:23091169 phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of NRP1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 pirinixic acid increases expression ISO RGD:1552955 6480464 pirinixic acid results in increased expression of NRP1 mRNA CTD PMID:18301758 pirinixic acid decreases expression ISO RGD:1552955 6480464 pirinixic acid results in decreased expression of NRP1 mRNA CTD PMID:23811191 piroxicam multiple interactions EXP 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of NRP1 mRNA CTD PMID:21858171 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:621588 6480464 Pregnenolone Carbonitrile results in decreased expression of NRP1 mRNA CTD PMID:19162173 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of NRP1 mRNA CTD PMID:20660070 propiconazole decreases expression ISO RGD:1552955 6480464 propiconazole results in decreased expression of NRP1 mRNA CTD PMID:21278054 Ptaquiloside multiple interactions ISO RGD:1552955 6480464 [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of NRP1 mRNA CTD PMID:23274088 quercetin affects expression EXP 6480464 Quercetin affects the expression of NRP1 mRNA CTD PMID:21632981 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of NRP1 mRNA CTD PMID:30152185 rotenone decreases expression ISO RGD:1552955 6480464 Rotenone results in decreased expression of NRP1 mRNA CTD PMID:19304788 rotenone increases expression EXP 6480464 Rotenone results in increased expression of NRP1 mRNA CTD PMID:29955902 sarin decreases expression EXP 6480464 Sarin results in decreased expression of NRP1 mRNA CTD PMID:19522546 sarin increases expression EXP 6480464 Sarin results in increased expression of NRP1 mRNA CTD PMID:19522546 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos increases expression EXP 6480464 Asbestos, Serpentine results in increased expression of NRP1 mRNA CTD PMID:29523930 silicon dioxide decreases expression ISO RGD:1552955 6480464 Silicon Dioxide results in decreased expression of NRP1 mRNA CTD PMID:19073995 simvastatin decreases response to substance EXP 6480464 NRP1 SNP results in decreased susceptibility to Simvastatin CTD PMID:21483694 sodium arsenate increases expression ISO RGD:1552955 6480464 sodium arsenate results in increased expression of NRP1 mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:1552955 6480464 sodium arsenite results in increased expression of NRP1 protein CTD PMID:29044176 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of NRP1 mRNA CTD PMID:17685462 Soman increases expression ISO RGD:621588 6480464 Soman results in increased expression of NRP1 mRNA CTD PMID:19281266 sphingosine 1-phosphate multiple interactions EXP 6480464 sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP1 mRNA], sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP1 mRNA] CTD PMID:15741222 succimer multiple interactions ISO RGD:1552955 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NRP1 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NRP1 mRNA CTD PMID:21641980 , PMID:26378955 succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP1 mRNA CTD PMID:26378955 sumatriptan multiple interactions ISO RGD:621588 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of NRP1 protein], Sumatriptan inhibits the reaction [Capsaicin results in increased expression of NRP1 protein] CTD PMID:22150557 tamoxifen affects expression ISO RGD:1552955 6480464 Tamoxifen affects the expression of NRP1 mRNA CTD PMID:20937368 Tesaglitazar increases expression ISO RGD:621588 6480464 tesaglitazar results in increased expression of NRP1 mRNA CTD PMID:21515302 tetrachloromethane affects expression ISO RGD:1552955 6480464 Carbon Tetrachloride affects the expression of NRP1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:1552955 6480464 [PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of NRP1 mRNA CTD PMID:29987408 thalidomide multiple interactions EXP 6480464 sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP1 mRNA] CTD PMID:15741222 thioacetamide increases expression ISO RGD:621588 6480464 Thioacetamide results in increased expression of NRP1 mRNA CTD PMID:19784758 titanium dioxide decreases expression ISO RGD:1552955 6480464 titanium dioxide results in decreased expression of NRP1 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:1552955 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NRP1 mRNA CTD PMID:29950665 toluene decreases expression ISO RGD:621588 6480464 Toluene results in decreased expression of NRP1 mRNA CTD PMID:22166486 toluene increases expression ISO RGD:621588 6480464 Toluene results in increased expression of NRP1 mRNA CTD PMID:22166486 , PMID:22967744 toluene 2,4-diisocyanate increases expression ISO RGD:1552955 6480464 Toluene 2, 4-Diisocyanate results in increased expression of NRP1 protein CTD PMID:27103660 topotecan multiple interactions ISO RGD:621588 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of NRP1 mRNA CTD PMID:25729387 topotecan decreases expression ISO RGD:621588 6480464 Topotecan results in decreased expression of NRP1 mRNA CTD PMID:25729387 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of NRP1 mRNA, trichostatin A results in increased expression of NRP1 protein CTD PMID:16330548 more ... trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of NRP1 mRNA CTD PMID:28542535 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of NRP1 mRNA CTD PMID:30510588 troglitazone decreases expression ISO RGD:1552955 6480464 troglitazone results in decreased expression of NRP1 mRNA CTD PMID:28973697 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of NRP1 mRNA CTD PMID:19140230 , PMID:25572481 urethane decreases expression EXP 6480464 Urethane results in decreased expression of NRP1 mRNA CTD PMID:28818685 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of NRP1 mRNA CTD PMID:24383497 more ... valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of NRP1 mRNA CTD PMID:28001369 , PMID:29154799 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA CTD PMID:27188386 vinclozolin affects expression ISO RGD:621588 6480464 vinclozolin affects the expression of NRP1 mRNA CTD PMID:19015723 zinc atom decreases expression ISO RGD:1552955 6480464 Zinc deficiency results in decreased expression of NRP1 mRNA CTD PMID:20857495 zinc(0) decreases expression ISO RGD:1552955 6480464 Zinc deficiency results in decreased expression of NRP1 mRNA CTD PMID:20857495
Biological Process actin cytoskeleton reorganization IMP 2290271 (PMID:24863063) BHF-UCL PMID:24863063 angiogenesis IMP 2290271 (PMID:23639442) BHF-UCL PMID:23639442 angiogenesis ISS UniProtKB:P97333 2290271 (PMID:24401374) BHF-UCL PMID:24401374 angiogenesis IEA InterPro:IPR027146 2290271 InterPro GO_REF:0000002 angiogenesis IEA InterPro:IPR014648 , InterPro:IPR027146 2290271 InterPro GO_REF:0000002 angiogenesis IEA InterPro:IPR014648 2290271 InterPro GO_REF:0000002 angiogenesis involved in coronary vascular morphogenesis ISS UniProtKB:P97333 2290271 (PMID:24401374) BHF-UCL PMID:24401374 animal organ morphogenesis TAS 2290271 (PMID:9529250) PINC PMID:9529250 animal organ morphogenesis IEA InterPro:IPR027146 2290271 InterPro GO_REF:0000002 artery morphogenesis ISS UniProtKB:P97333 2290271 (PMID:23639442), (PMID:24401374) BHF-UCL PMID:23639442 , PMID:24401374 axon extension involved in axon guidance ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 axon guidance NAS 2290271 (PMID:19909241) BHF-UCL PMID:19909241 axon guidance IEA InterPro:IPR027146 2290271 InterPro GO_REF:0000002 axon guidance IEA InterPro:IPR014648 2290271 InterPro GO_REF:0000002 axon guidance IEA InterPro:IPR014648 , InterPro:IPR027146 2290271 InterPro GO_REF:0000002 axonal fasciculation IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 axonogenesis involved in innervation ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 basal dendrite arborization ISS UniProtKB:P97333 2290271 (PMID:22683681) ARUK-UCL PMID:22683681 basal dendrite development ISS UniProtKB:P97333 2290271 (PMID:22683681) ARUK-UCL PMID:22683681 branching involved in blood vessel morphogenesis ISS UniProtKB:P97333 2290271 (PMID:24401374) BHF-UCL GO_REF:0000024, PMID:24401374 branchiomotor neuron axon guidance IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 cell migration involved in sprouting angiogenesis ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 cell-cell signaling TAS 2290271 (PMID:9288753) PINC PMID:9288753 cellular response to hepatocyte growth factor stimulus IMP 2290271 (PMID:21245381) BHF-UCL PMID:21245381 cellular response to vascular endothelial growth factor stimulus ISS UniProtKB:P97333 2290271 (PMID:24401374) BHF-UCL PMID:24401374 commissural neuron axon guidance ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 coronary artery morphogenesis IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 dichotomous subdivision of terminal units involved in salivary gland branching IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 dorsal root ganglion morphogenesis IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 endothelial cell chemotaxis IMP 2290271 (PMID:21245381) BHF-UCL PMID:21245381 endothelial cell chemotaxis IEA InterPro:IPR027146 2290271 InterPro GO_REF:0000002 endothelial cell migration IMP 2290271 (PMID:24863063) BHF-UCL PMID:24863063 endothelial tip cell fate specification ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 facial nerve structural organization IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 facioacoustic ganglion development IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 gonadotrophin-releasing hormone neuronal migration to the hypothalamus IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 hepatocyte growth factor receptor signaling pathway IMP 2290271 (PMID:21245381) BHF-UCL PMID:21245381 integrin-mediated signaling pathway IMP 2290271 (PMID:24863063), (PMID:26051942) BHF-UCL PMID:24863063 , PMID:26051942 motor neuron migration ISS UniProtKB:P97333 2290271 UniProtKB GO_REF:0000024 negative regulation of axon extension involved in axon guidance IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 negative regulation of axon extension involved in axon guidance IEA UniProtKB:Q9QWJ9 , ensembl:ENSRNOP000000750342290271 Ensembl GO_REF:0000107 negative regulation of extrinsic apoptotic signaling pathway IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 negative regulation of neuron apoptotic process IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 nerve development ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 neural crest cell migration involved in autonomic nervous system development ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 neuron migration ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 neuropilin signaling pathway IMP 2290271 (PMID:24863063), (PMID:26051942) BHF-UCL PMID:24863063 , PMID:26051942 otic placode development IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 outflow tract septum morphogenesis ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 platelet-derived growth factor receptor signaling pathway IMP 2290271 (PMID:21245381) BHF-UCL PMID:21245381 positive chemotaxis ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 positive regulation of actin cytoskeleton reorganization IMP 2290271 (PMID:24863063), (PMID:26051942) BHF-UCL PMID:24863063 , PMID:26051942 positive regulation of axon extension involved in axon guidance ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 positive regulation of cell migration involved in sprouting angiogenesis IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 positive regulation of cytokine activity TAS 2290271 (PMID:21245381) BHF-UCL PMID:21245381 positive regulation of endothelial cell migration TAS 2290271 (PMID:21245381) BHF-UCL PMID:21245381 positive regulation of endothelial cell migration IMP 2290271 (PMID:24863063) BHF-UCL PMID:24863063 positive regulation of endothelial cell proliferation TAS 2290271 (PMID:21245381) BHF-UCL PMID:21245381 positive regulation of ERK1 and ERK2 cascade ISS UniProtKB:P97333 2290271 (PMID:23639442) BHF-UCL PMID:23639442 positive regulation of filopodium assembly IMP 2290271 (PMID:26051942) BHF-UCL PMID:26051942 positive regulation of focal adhesion assembly IDA 2290271 (PMID:24863063) BHF-UCL PMID:24863063 positive regulation of GTPase activity IEA GO:0005096 2290271 GOC GO_REF:0000108 positive regulation of peptidyl-tyrosine phosphorylation IMP 2290271 (PMID:21245381) BHF-UCL PMID:21245381 positive regulation of phosphorylation IMP 2290271 (PMID:24863063) BHF-UCL PMID:24863063 positive regulation of retinal ganglion cell axon guidance ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 positive regulation of smooth muscle cell migration TAS 2290271 (PMID:21245381) BHF-UCL PMID:21245381 positive regulation of stress fiber assembly IMP 2290271 (PMID:26051942) BHF-UCL PMID:26051942 positive regulation of substrate adhesion-dependent cell spreading IMP 2290271 (PMID:24863063) BHF-UCL PMID:24863063 postsynapse organization IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 protein localization to early endosome ISS UniProtKB:P97333 2290271 (PMID:23639442) BHF-UCL PMID:23639442 regulation of Cdc42 protein signal transduction IMP 2290271 (PMID:26051942) BHF-UCL PMID:26051942 regulation of retinal ganglion cell axon guidance ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 regulation of vesicle-mediated transport TAS 2290271 (PMID:21245381) BHF-UCL PMID:21245381 renal artery morphogenesis IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 response to wounding IEA UniProtKB:Q9QWJ9 , ensembl:ENSRNOP000000750342290271 Ensembl GO_REF:0000107 retina vasculature morphogenesis in camera-type eye ISS UniProtKB:P97333 2290271 (PMID:24401374) BHF-UCL PMID:24401374 retinal ganglion cell axon guidance ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 semaphorin-plexin signaling pathway NAS 2290271 (PMID:19909241) BHF-UCL PMID:19909241 semaphorin-plexin signaling pathway IEA GO:0017154 2290271 GOC GO_REF:0000108 semaphorin-plexin signaling pathway IEA InterPro:IPR027146 2290271 InterPro GO_REF:0000002 semaphorin-plexin signaling pathway involved in axon guidance IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 semaphorin-plexin signaling pathway involved in neuron projection guidance ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 sensory neuron axon guidance IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 signal transduction TAS 2290271 (PMID:9288753) PINC PMID:9288753 sprouting angiogenesis ISS UniProtKB:P97333 2290271 (PMID:24401374) BHF-UCL PMID:24401374 substrate adhesion-dependent cell spreading IMP 2290271 (PMID:24863063) BHF-UCL PMID:24863063 substrate-dependent cell migration, cell extension IMP 2290271 (PMID:24863063) BHF-UCL PMID:24863063 sympathetic ganglion development ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 sympathetic neuron projection extension ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 sympathetic neuron projection guidance ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 toxin transport IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 trigeminal ganglion development IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 trigeminal nerve structural organization IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 vascular endothelial growth factor receptor signaling pathway IMP 2290271 (PMID:21245381) BHF-UCL PMID:21245381 vascular endothelial growth factor receptor signaling pathway TAS 2290271 Reactome Reactome:R-HSA-194138 vascular endothelial growth factor receptor signaling pathway IEA InterPro:IPR027146 2290271 InterPro GO_REF:0000002 vascular endothelial growth factor signaling pathway IEA GO:0005021 2290271 GOC GO_REF:0000108 vascular endothelial growth factor signaling pathway IEA InterPro:IPR014648 2290271 InterPro GO_REF:0000002 VEGF-activated neuropilin signaling pathway ISS UniProtKB:P97333 2290271 (PMID:23639442) BHF-UCL PMID:23639442 VEGF-activated neuropilin signaling pathway IMP 2290271 (PMID:24863063) BHF-UCL PMID:24863063 VEGF-activated neuropilin signaling pathway involved in axon guidance IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 ventral trunk neural crest cell migration IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 vestibulocochlear nerve structural organization IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 Cellular Component axon ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 cell surface IEA UniProtKB:Q9QWJ9 , ensembl:ENSRNOP000000750342290271 Ensembl GO_REF:0000107 cytoplasmic vesicle TAS 2290271 (PMID:21245381) BHF-UCL PMID:21245381 cytosol IDA 2290271 (PMID:21245381) BHF-UCL PMID:21245381 early endosome ISS UniProtKB:P97333 2290271 (PMID:23639442) BHF-UCL PMID:23639442 extracellular space HDA 2290271 (PMID:16502470) UniProtKB PMID:16502470 focal adhesion HDA 2290271 (PMID:21423176) UniProtKB PMID:21423176 focal adhesion IDA 2290271 (PMID:24863063) BHF-UCL PMID:24863063 glutamatergic synapse IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 growth cone IEA UniProtKB:Q9QWJ9 , ensembl:ENSRNOP000000750342290271 Ensembl GO_REF:0000107 integral component of membrane IEA UniProtKB-KW:KW-0812 2290271 UniProtKB GO_REF:0000038 integral component of postsynaptic membrane IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 membrane IEA UniProtKB-KW:KW-0472 2290271 UniProtKB GO_REF:0000038 mitochondrial membrane IEA UniProtKB-SubCell:SL-0171 2290271 UniProt GO_REF:0000039 neurofilament IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 neuron projection ISS UniProtKB:P97333 2290271 (PMID:22683681) ARUK-UCL PMID:22683681 neuronal cell body IEA UniProtKB:Q9QWJ9 , ensembl:ENSRNOP000000750342290271 Ensembl GO_REF:0000107 plasma membrane IDA 2290271 (PMID:21245381) BHF-UCL PMID:21245381 plasma membrane TAS 2290271 Reactome Reactome:R-HSA-195408 more ... receptor complex TAS 2290271 (PMID:21245381) BHF-UCL PMID:21245381 semaphorin receptor complex NAS 2290271 (PMID:19909241) BHF-UCL PMID:19909241 sorting endosome ISS UniProtKB:P97333 2290271 (PMID:23639442) BHF-UCL PMID:23639442 Molecular Function coreceptor activity TAS 2290271 (PMID:21245381) BHF-UCL PMID:21245381 cytokine binding NAS 2290271 (PMID:19909241) BHF-UCL PMID:19909241 growth factor binding IPI UniProtKB:P15692-4 2290271 (PMID:9529250) UniProtKB PMID:9529250 growth factor binding IEA InterPro:IPR027146 2290271 InterPro GO_REF:0000002 growth factor binding TAS 2290271 (PMID:21245381) BHF-UCL PMID:21245381 GTPase activator activity IMP 2290271 (PMID:26051942) BHF-UCL PMID:26051942 heparin binding IEA UniProtKB-KW:KW-0358 2290271 UniProtKB GO_REF:0000037 metal ion binding IEA UniProtKB-KW:KW-0479 2290271 UniProtKB GO_REF:0000037 metal ion binding IEA UniRule:UR000356805 2290271 UniProtKB GO_REF:0000104 protein binding IPI UniProtKB:P21333 2290271 (PMID:24021649) IntAct PMID:24021649 protein binding IPI UniProtKB:P49023 2290271 (PMID:24863063) BHF-UCL PMID:24863063 protein binding IPI UniProtKB:P00519 2290271 (PMID:24863063) BHF-UCL PMID:24863063 protein binding IPI UniProtKB:P15692 2290271 (PMID:16763549), (PMID:17222790) IntAct PMID:16763549 , PMID:17222790 protein binding IPI UniProtKB:P35968 2290271 (PMID:16763549), (PMID:17222790) IntAct PMID:16763549 , PMID:17222790 protein binding IPI UniProtKB:P08648 2290271 (PMID:19175293) IntAct PMID:19175293 protein binding IPI UniProtKB:P15692-4 2290271 (PMID:22897854) IntAct PMID:22897854 protein kinase binding IEA UniProtKB:P97333 , ensembl:ENSMUSP000000269172290271 Ensembl GO_REF:0000107 semaphorin receptor activity NAS 2290271 (PMID:19909241) BHF-UCL PMID:19909241 semaphorin receptor activity IEA InterPro:IPR027146 2290271 InterPro GO_REF:0000002 semaphorin receptor activity IEA InterPro:IPR014648 2290271 InterPro GO_REF:0000002 semaphorin receptor activity IEA InterPro:IPR014648 , InterPro:IPR027146 2290271 InterPro GO_REF:0000002 vascular endothelial growth factor binding IPI UniProtKB:P15692-4 2290271 (PMID:24401374) BHF-UCL PMID:24401374 vascular endothelial growth factor-activated receptor activity NAS 2290271 (PMID:19909241) BHF-UCL PMID:19909241 vascular endothelial growth factor-activated receptor activity IEA InterPro:IPR027146 2290271 InterPro GO_REF:0000002 vascular endothelial growth factor-activated receptor activity IEA InterPro:IPR014648 2290271 InterPro GO_REF:0000002 vascular endothelial growth factor-activated receptor activity ISS UniProtKB:P97333 2290271 BHF-UCL GO_REF:0000024 vascular endothelial growth factor-activated receptor activity IEA InterPro:IPR014648 , InterPro:IPR027146 2290271 InterPro GO_REF:0000002
Gene-Chemical Interaction Annotations
